Impact of Preoperative Biliary Drainage on Long-Term Survival in Resected Pancreatic Ductal Adenocarcinoma: A Multicenter Observational Study

Annals of Surgical Oncology

Volumn 22, Issue , 2015, Pages 1238-1246

  Uemura, Kenichiro ^a   Murakami, Yoshiaki ^a   Satoi, Sohei ^b   Sho, Masayuki ^c   Motoi, Fuyuhiko ^d   Kawai, Manabu ^e   Matsumoto, Ippei ^f   Honda, Goro ^g   Kurata, Masanao ^g   Yanagimoto, Hiroaki ^b   Nishiwada, Satoshi ^c   Fukumoto, Takumi ^f   Unno, Michiakil ^d   Yamaue, Hiroki ^e  

^a HIROSHIMA UNIVERSITY   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

^e WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL ABSCESS; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BILIARY TRACT DRAINAGE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ENDOSCOPIC BILIARY DRAINAGE; ENDOSCOPIC SURGERY; FEMALE; HIGH VOLUME HOSPITAL; HUMAN; INDEPENDENT VARIABLE; JAPAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; METAL STENT; NASOBILIARY TUBE; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS FISTULA; PANCREATICODUODENECTOMY; PERCUTANEOUS TRANSHEPATIC DRAINAGE; PERITONEUM METASTASIS; PLASTIC STENT; PREOPERATIVE TREATMENT; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL INFECTION; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; ADVERSE EFFECTS; CANCER STAGING; CARCINOMA, PANCREATIC DUCTAL; CASE CONTROL STUDY; CHOLESTASIS; CLINICAL TRIAL; DRAINAGE; ENDOSCOPY; FOLLOW UP; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PANCREAS RESECTION; PANCREATIC NEOPLASMS; PATHOLOGY; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; SECONDARY; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; CHOLESTASIS; DRAINAGE; ENDOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84952874384     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4618-9     Document Type: Article

References (24)

1. Eshuis WJ, van der Gaag NA, Rauws EA, et al. Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage. Ann Surg. 2010;252:840–9.
2. Sewnath ME, Karsten TM, Prins MH, Rauws EJ, Obertop H, Gouma DJ. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg. 2002;236:17–27.
3. van der Gaag NA, Rauws EA, van Eijck CH, et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med. 2010;362:129–37.
4. Iacono C, Ruzzenente A, Campagnaro T, Bortolasi L, Valdegamberi A, Guglielmi A. Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacks. Ann Surg. 2013;257:191–204.
5. Jinkins LJ, Parmar AD, Han Y, et al. Current trends in preoperative biliary stenting in patients with pancreatic cancer. Surgery. 2013;154:179–89.
6. Smith RA, Dajani K, Dodd S, et al. Preoperative resolution of jaundice following biliary stenting predicts more favourable early survival in resected pancreatic ductal adenocarcinoma. Ann Surg Oncol.2008;15:3138–46.
7. di Mola FF, Tavano F, Rago RR, et al. Influence of preoperative biliary drainage on surgical outcome after pancreaticoduodenectomy: single-centre experience. Langenbeck’s Arch Surg. 2014;399:649–57.
8. Hirano S, Tanaka E, Tsuchikawa T, et al. Oncological benefit of preoperative endoscopic biliary drainage in patients with hilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2014;21:533–40.
9. Nagai S, Fujii T, Kodera Y, et al. Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas. Pancreas. 2011;40:3–9.
10. Cameron JL, Crist DW, Sitzmann JV, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg. 1991;161:120–4; discussion 124–5.
11. Mu DQ, Peng SY, Wang GF. Risk factors influencing recurrence following resection of pancreatic head cancer. World J Gastroenterol. 2004;10:906–9.
12. Schnelldorfer T, Ware AL, Sarr MG, et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg. 2008;247:456–62.
13. Doi R, Kami K, Ito D, et al. Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer. World J Surg. 2007;31:147–54.
14. Cordera F, Arciero CA, Li T, Watson JC, Hoffman JP. Significance of common hepatic artery lymph node metastases during pancreaticoduodenectomy for pancreatic head adenocarcinoma. Ann Surg Oncol. 2007;14:2330–6.
15. Sierzega M, Popiela T, Kulig J, Nowak K. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer. Pancreas. 2006;33:240–5.
16. Pawlik TM, Gleisner AL, Cameron JL, et al. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery. 2007;141:610–18.
17. Rau BM, Moritz K, Schuschan S, Alsfasser G, Prall F, Klar E. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use. Surgery. 2012;152(3 Suppl 1):S103–11.
18. Fukuda S, Oussoultzoglou E, Bachellier P, et al. Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma. Arch Surg. 2007;142:172–9; discussion 180.
19. Valle JW, Palmer D, Jackson R, et al. Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. J Clin Oncol. 2014;32:504–12.
20. La Torre M, Nigri G, Cavallini M, Mercantini P, Ziparo V, Ramacciato G. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma. Ann Surg Oncol. 2012;19:2917–23.
21. Szkandera J, Stotz M, Absenger G, et al. Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients. Br J Cancer. 2014;110:183–8.
22. Takahashi H, Ohigashi H, Ishikawa O, et al. Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based chemoradiation therapy for resectable pancreatic cancer. Ann Surg. 2012;255:95–102.
23. Hata S, Sakamoto Y, Yamamoto Y, et al. Prognostic impact of postoperative serum CA 19-9 levels in patients with resectable pancreatic cancer. Ann Surg Oncol. 2012;19:636–41.
24. Chapman WC, Sharp KW, Weaver F, Sawyers JL. Tumor seeding from percutaneous biliary catheters. Ann Surg. 1989;209:708–13; discussion 713–705.